{"id":"W2782629081","doi":"10.1200/jco.2016.34.15_suppl.tps2604","title":"ROAR: a phase 2, open-label study in patients (pts) with BRAF V600E–mutated rare cancers to investigate the efficacy and safety of dabrafenib (D) and trametinib (T) combination therapy.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Trametinib; Oncology; Cancer; Melanoma; V600E; Gastroenterology; Cancer research; Mutation","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002711296,0.001898622,0.002488615,0.0005092657,0.0004663448,0.00100829,0.001140218,0.001465765,0.005474241],"category_scores_gemma":[0.001351195,0.000806781,0.001683056,0.0005049321,0.001243374,0.001614167,0.0004933056,0.004476125,0.002131319],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000756044,"about_ca_system_score_gemma":0.001857428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004827303,"about_ca_topic_score_gemma":0.001646514,"domain_scores_codex":[0.9990997,0.000514682,0.00003594564,0.0001418499,0.00008459596,0.0001232786],"domain_scores_gemma":[0.9989663,0.0001659039,0.0002538705,0.0001019316,0.00006991495,0.0004419983],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7304559,0.135826,0.01161294,0.001312196,0.002109702,0.0005352856,0.0003918664,0.003045606,0.03072915,0.0007443192,0.01025477,0.07298215],"study_design_scores_gemma":[0.6052667,0.3798015,0.007205231,0.00003240352,0.0005207921,0.0005653984,0.00009229417,0.001359801,0.001206265,0.0002898476,0.003620791,0.00003890374],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9851805,0.001686881,0.001382935,0.0008632538,0.0001917774,0.005380557,0.002516601,0.0002740203,0.002523501],"genre_scores_gemma":[0.96867,0.001872664,0.007107394,0.0023801,0.0003905903,0.01088929,0.004905412,0.0001027245,0.003681877],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005474241,"threshold_uncertainty_score":0.01831317,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07249467770115313,"score_gpt":0.4216821714807678,"score_spread":0.3491874937796146,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}